The University of Houston's medical school will ask the Texas legislature for $200 million to build a community hospital in ...

Analyst Tami Zakaria of J.P. Morgan maintained a Buy rating on Caterpillar (CAT – Research Report), reducing the price target to $490.00.Invest ...

Apple Inc. (NASDAQ:AAPL), the tech giant known for its innovative products and services, finds itself at a critical juncture ...

A recent study from Purdue University scientists reveals following a consistent dietary pattern that features lean red meat can contribute to gut microbiota balance and support cardiovascular health.

Analyst Samik Chatterjee from J.P. Morgan maintained a Buy rating on Qualcomm (QCOM – Research Report) and keeping the price target at ...

The Motley Fool reaches millions of people every month through our premium investing solutions, free guidance and market analysis on Fool.com, personal finance education, top-rated podcasts, and ...

We are huge fans of Five Ten here at MBR HQ and right now Evans Cycles is having a huge sale on the Five Ten range with some insane discounts. You can grab the Five Ten Freerider Pro Canvas for just ...

Editor’s note: If it feels as though the world is changing, that’s because it is. Global economic reconfiguration, demographic decline and geopolitical realignment have fundamentally altered long-held ...

Welcome to day 1 of the J.P. Morgan Healthcare Conference, the industry's most significant dealmaking event each year. For the 43rd edition of the JPM conference, Johnson & Johnson stole the ...

J.P. Morgan Payments, the payments arm of banking giant JPMorgan Chase & Co., is blazing its own path with two new payment terminals, both proprietary to the payment service. Announced Monday, the J.P ...

The deal would help accelerate growth in J&J's drugs business after the company spun off its consumer health unit in 2023. It has made several transactions in the past few years to boost its ...

J&J's $132 per-share offer implies 39% premium Deal could kick off spree of activity in sector in 2025 CEO says such large deals not common The deal would help accelerate growth in J&J's drugs ...